azides has been researched along with Lymphoma, T-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benacerraf, B; Clark, K; Kovacsovics-Bankowski, M; Rock, KL | 1 |
Ling, V; Rischin, D | 1 |
2 other study(ies) available for azides and Lymphoma, T-Cell
Article | Year |
---|---|
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
Topics: Animals; Antigen-Presenting Cells; Azides; Cell Line; Cytochalasin B; Deoxyglucose; Female; Histocompatibility Antigens Class I; Kinetics; Lymphoma, T-Cell; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Phagocytosis; Spleen; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 1993 |
Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).
Topics: Animals; Antineoplastic Agents; Azides; Biological Transport; Carboplatin; Cell Line; Chromatography, High Pressure Liquid; Cisplatin; Drug Resistance, Neoplasm; Kinetics; Lymphoma, T-Cell; Mice; Organoplatinum Compounds; Sodium Azide; Sulfhydryl Compounds; Tumor Cells, Cultured | 1996 |